Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM4 | Q14833 | 11/20 | 0.67 |
| ▸ | TSHR | P16473 | 1/20 | 0.62 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.61 |
| ▸ | NPC1 | O15118 | 2/20 | 0.61 |
| ▸ | RAB9A | P51151 | 2/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.61 |
| ▸ | GRM5 | P41594 | 3/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.58 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24298091 | 1.00 | GRM4 (0.67) | GRM4TSHRHDAC6NPC1RAB9A | |
| SCHEMBL29217385 | 0.88 | GRM4 (0.61) | GRM4TSHRHDAC6RAB9AKMT2A | |
| SCHEMBL28871721 | 0.87 | GAA (0.60) | GRM4TSHRHDAC6NPC1RAB9A | |
| SCHEMBL28443847 | 0.85 | GRM4 (0.62) | GRM4HDAC6NPC1RAB9AGRM5 | |
| SCHEMBL11666088 | 0.84 | GRM4 (0.62) | GRM4HDAC6NPC1RAB9A | |
| SCHEMBL5697349 | 0.83 | GRM4 (0.69) | GRM4HDAC6NPC1RAB9AKMT2A | |
| SCHEMBL28625315 | 0.82 | GRM4 (0.59) | GRM4HDAC6NPC1RAB9AKMT2A | |
| SCHEMBL29644059 | 0.82 | GRM4 (0.59) | GRM4HDAC6NPC1RAB9AKMT2A | |
| Ammonia Solution, Strong SCHEMBL20302203 | 0.82 | MCL1 (0.69) | GRM4HDAC6NPC1RAB9AKMT2A | |
| SCHEMBL4522324 | 0.81 | HDAC1 (0.69) | GRM4HDAC6NPC1RAB9AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118960176-A | Control method of air supply device and air supply device | 广东松下环境系统有限公司 | 2024-11-15 | — | — | CN | disclosed |
| CN-116966891-A | Titanium-aluminum composite carrier, preparation method thereof, hydrogenation catalyst and heavy petroleum distillate hydrogenation catalyst | 中国石油大学(北京) | 2023-10-31 | — | — | CN | disclosed |
| US-20220118117-A1 | MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR 4 | MASSACHUSETTS GEN HOSPITAL (US) | 2022-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220118117-A1 | MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR 4 | GRM2, GRM4, GRM1 | GRM4 2/4885TSHR 580/4885HDAC6 2334/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.